Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAY RODRIGUEZ

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1154324366
CMS profile
51479
Location
TEMPLE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$20,604.57

27 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Shire North American Group Inc $20,466.05 25
GlaxoSmithKline, LLC. $123.62 1
Astellas Pharma US Inc $14.90 1

Page 1 of 1; records 1–27 of 27 matching records. This page contains 27 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAY RODRIGUEZ

NPI 1154324366 · CMS profile ID 51479

Allopathic & Osteopathic Physicians / Allergy & Immunology

TEMPLE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–27 of 27 matching records. This page contains 27 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1154324366?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAY RODRIGUEZ, NPI 1154324366, CMS profile ID 51479. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–27 of 27 matching records. This page contains 27 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1154324366?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). RAY RODRIGUEZ, NPI 1154324366, CMS profile ID 51479. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–27 of 27 matching records. This page contains 27 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1154324366?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
RAY RODRIGUEZ, NPI 1154324366, CMS profile ID 51479, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–27 of 27 matching records. This page contains 27 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1154324366?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

27 matching records · $20,604.57 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 27 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–27 of 27.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $123.6211/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671407227 CMS
Astellas Pharma US Inc $14.9010/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655743899 CMS
Shire North American Group Inc $4,162.5005/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905779 CMS
Shire North American Group Inc $4,162.5005/14/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905777 CMS
Shire North American Group Inc $18.5605/06/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905765 CMS
Shire North American Group Inc $6.3505/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905767 CMS
Shire North American Group Inc $16.7305/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905769 CMS
Shire North American Group Inc $3.2305/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905771 CMS
Shire North American Group Inc $18.5605/06/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905773 CMS
Shire North American Group Inc $28.0005/06/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905775 CMS
Shire North American Group Inc $675.4804/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905763 CMS
Shire North American Group Inc $4,162.5004/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905761 CMS
Shire North American Group Inc $207.8804/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905755 CMS
Shire North American Group Inc $65.0004/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905757 CMS
Shire North American Group Inc $447.9104/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905759 CMS
Shire North American Group Inc $900.0004/11/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905753 CMS
Shire North American Group Inc $4,162.5004/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905743 CMS
Shire North American Group Inc $20.8804/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905745 CMS
Shire North American Group Inc $24.0004/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905747 CMS
Shire North American Group Inc $6.0104/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905749 CMS
Shire North American Group Inc $16.5004/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905751 CMS
Shire North American Group Inc $53.5303/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905739 CMS
Shire North American Group Inc $534.8003/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905741 CMS
Shire North American Group Inc $123.6003/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905731 CMS
Shire North American Group Inc $61.5703/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905733 CMS
Shire North American Group Inc $473.5903/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905735 CMS
Shire North American Group Inc $113.8703/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637905737 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $20,604.57 27
PY2020 $4,623.78 4
PY2021 $1,779.32 4
PY2022 $90.08 2
PY2023 $174.22 3
PY2024 $635.49 5
PY2025 $494.55 10

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $62,146.01 31
PY2021 Principal investigator $4,000.00 2
PY2020 Principal investigator $8,000.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $800.00 09/12/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130907010
Principal investigator 1 PFIZER INC. $2,234.18 08/19/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905566
Principal investigator 1 PFIZER INC. $337.50 08/16/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130906415
Principal investigator 1 PFIZER INC. $3,270.00 08/16/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130908123
Principal investigator 1 GLOBAL BLOOD THERAPEUTICS, INC. $1,137.50 07/31/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine PC
AN OPEN LABEL OBSERVATIONAL PROSPECTIVE REGISTRY OF PARTICIPANTS WITH SICKLE CELL DISEASE SCD TREATED WITH OXBRYTA VOXELOTOR No dispute reported 06/30/2026 1130908555
Principal investigator 1 GLOBAL BLOOD THERAPEUTICS, INC. $1,020.60 07/31/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine PC
AN OPEN LABEL OBSERVATIONAL PROSPECTIVE REGISTRY OF PARTICIPANTS WITH SICKLE CELL DISEASE SCD TREATED WITH OXBRYTA VOXELOTOR No dispute reported 06/30/2026 1130908823
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $500.00 07/24/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130908792
Principal investigator 1 PFIZER INC. $1,600.00 07/10/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905889
Principal investigator 1 PFIZER INC. $1,883.00 07/10/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905893
Principal investigator 1 PFIZER INC. $225.00 07/10/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905897
Principal investigator 1 PFIZER INC. $524.00 07/02/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905559
Principal investigator 1 PFIZER INC. $998.00 07/02/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905563
Principal investigator 1 PFIZER INC. $2,234.18 06/06/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130905394
Principal investigator 1 Amgen Inc. $13,000.00 05/24/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE - OLD CANTON ROAD
ORBIT P3 AD Adolescent Open Label Safety No dispute reported 06/30/2026 1096311851
Principal investigator 1 PFIZER INC. $1,738.00 04/19/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130905912
Principal investigator 1 PFIZER INC. $337.50 04/05/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130908827
Principal investigator 1 PFIZER INC. $440.00 04/01/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130905275
Principal investigator 1 Amgen Inc. $957.61 03/26/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE - OLD CANTON ROAD
ORBIT P3 AD Adolescent Open Label Safety No dispute reported 06/30/2026 1096311853
Principal investigator 1 PFIZER INC. $95.00 03/22/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130906058
Principal investigator 1 PFIZER INC. $1,972.00 03/22/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130906384
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $1,000.00 03/21/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130905702
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $250.00 03/21/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130906349
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $14,950.97 03/14/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130906019
Principal investigator 1 PFIZER INC. $2,234.18 02/21/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130909856
Principal investigator 1 PFIZER INC. $800.00 02/07/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCED MEDICINE PC
AN OPENLABEL EXTENSION STUDY TO EVALUATE THE LONGTERM SAFETY OF GBT021601 ADMINISTERED TO PARTICIPANTS WITH SICKLE CELL DISEASE WHO HAVE PARTICIPATED IN A GBT021601 CLINICAL TRIAL No dispute reported 06/30/2026 1130906672
Principal investigator 1 GLOBAL BLOOD THERAPEUTICS, INC. $1,020.60 01/24/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine PC
AN OPEN LABEL OBSERVATIONAL PROSPECTIVE REGISTRY OF PARTICIPANTS WITH SICKLE CELL DISEASE SCD TREATED WITH OXBRYTA VOXELOTOR No dispute reported 06/30/2026 1130905528
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $137.28 01/19/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130905698
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $101.17 01/19/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130906015
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $84.77 01/19/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130906023
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $69.17 01/19/2024 Non-covered Recipient Entity
Mississippi Center for Advanced Medicine
A PHASE 23 RANDOMIZED MULTICENTER STUDY OF GBT021601 ADMINISTERED ORALLY TO PARTICIPANTS WITH SICKLE CELL DISEASE AND AN OPENLABEL PHARMACOKINETICS STUDY IN PEDIATRIC PARTICIPANTS WITH SICKLE CELL DISEASE No dispute reported 06/30/2026 1130908358
Principal investigator 1 PFIZER INC. $6,193.80 01/16/2024 Non-covered Recipient Entity
MISSISSIPPI CENTER FOR ADVANCE MEDICINE
A FACTOR IX FIX GENE TRANSFER MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B No dispute reported 06/30/2026 1130911678